The Motley Fool

Incyte Aktie (NASDAQ:INCY)

Incyte isn't the only drugmaker with a JAK inhibitor, but Jakafi's differentiation as a JAK1 and JAK2 inhibitor has helped the company stay on top of the treatment paradigm for myelofibrosis.

$84.03 $1.49 (1.8%) Mittwoch, 7. Dezember 2022 um 22:00:00 Mitteleuropäische Normalzeit

About

Last updated 07-12-2022, 10:00:00pm CET
Aktueller Kurs $84.03
Veränderung $1.49 (1.8%)
Schlusskurs $84.03
Eröffnung $82.57
Geld $75.01
Brief $85.50
Tagesspanne $82.32 - $84.13
52-Wochen-Spanne $64.32 - $84.86
Volumen 1,145,379
Durchschn. Volumen 1,481,074
Marktkapitalisierung $18,363,125,128.00
EPS (roll. Hochrechn.) $4.23

Related Articles